Crenezumab for Mild to Moderate Alzheimer Disease

Language
Undefined

Purpose: To evaluate the safety and tolerability of crenezumab in older adults with mild to moderate Alzheimer's disease.

Source: Alzheimers Clinical Trials - February 25, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials